• Written by Amy Peacock, Senior Research Fellow, UNSW

There’s no question COVID-19 has changed many aspects of our lives. As drug researchers, we are interested in how the pandemic has affected illicit drug use in Australia.

Our two new surveys of Australians who regularly use illicit drugs show people most commonly reported no change or a reduction in their use of various illicit drugs since COVID-19 restrictions came into effect.

While this may be perceived as a good thing, for people who regularly use drugs, a period of decreased use can heighten the risk of adverse effects, such as overdose, later on.

Read more: Drug use may increase the risk of coronavirus. Here's how to reduce the harms

Tracking drug trends

Many experts, ourselves included, predicted significant shifts in drug trends as governments around the world introduced restrictions to control the spread of COVID-19.

Evidence from major environmental, economic, and other past crises suggests the COVID-19 pandemic may have substantial effects on:

  1. drug use (for example, switching to different substances or being unable to obtain drugs)

  2. drug procurement (for example, shifts to online purchasing and buying drugs in larger quantities)

  3. drug markets (for example, changes in price, purity and availability of illicit drugs).

These changes may increase the risk of drug-related harms, such as withdrawal, drug dependence and overdose. This could be especially problematic given challenges in delivery of drug treatment and harm-reduction services during COVID-19.

how coronavirus is changing the way we use drugs Two in five people we surveyed said they were using cannabis more during COVID-19. Shutterstock

We wanted to see if Australians who use illicit drugs had experienced these changes.

We conducted telephone interviews with 350 Australians who live in capital cities and regularly use ecstasy and other illicit stimulants.

We also conducted an online survey of 702 Australians who regularly used illicit drugs in 2019.

We recruited participants for both studies between April and June via social media.

Drug use

Overall, we found the use of most illicit substances had largely remained stable or decreased since March. People most commonly reported they were using drugs like MDMA, ketamine and LSD at a similar level or less than they were before the pandemic.

Conversely, at least two in five people across both studies reported they were using more cannabis than before COVID-19.

These findings are unsurprising given cannabis is mostly used in private homes, whereas drugs like MDMA are more commonly used in public settings such as nightclubs or festivals.

Drug procurement

Most participants across both studies continued to obtain drugs face-to-face. But about 10% reported they had reduced face-to-face collection of drugs, obtained drugs less frequently, and bought drugs in larger quantities since COVID-19 restrictions.

People also reported trying to reduce the risk of contracting COVID-19 by washing their hands before handling drugs, and avoiding sharing equipment such as pipes, bongs, needles and syringes.

And about 10% of participants reported seeking information on how to reduce their risk of COVID-19 when using drugs.

These findings refute stigmatised views that people who use illicit drugs are reckless with their health.

Read more: Drug use can have social benefits, and acknowledging this could improve rehabilitation

Drug markets

Our participants largely perceived the illicit substances they sought were no less available since the start of restrictions.

The exception was MDMA pills; half of participants we interviewed by phone said they were “more difficult” to obtain.

These findings are surprising given illicit drugs like heroin, cocaine and methamphetamine are typically detected at the Australian border, and air travel has been restricted with COVID-19.

However, the effects of COVID-19 on price, purity and availability of drugs may take time to become apparent and will vary by substance.

Reduced drug use is not always a positive

Participants commonly said their reduced substance use was a result of limited opportunities to “go out” and socialise. So as restrictions start to ease, it seems likely people will again increase their use of substances like MDMA and cocaine.

Resuming substance use after a period of abstinence or reduced use can increase the risk of harms such as overdose due to reduced tolerance to the effects of the drug.

how coronavirus is changing the way we use drugs Fewer social gatherings like festivals means less use of some illicit substances. Shutterstock

Harm-reduction strategies — like taking smaller doses, spreading out doses during a session and having a sober person present — can help reduce the risk of these outcomes if people start to use drugs again or use larger amounts.

Peer-based organisations and online resources offer information and advice on how to reduce risk when using drugs.

Read more: Parents of teens, here's what you really need to know about MDMA

We need broader research

Our samples mainly comprised young, educated capital city dwellers recruited via social media. Very few of our participants reported drug dependence or were engaged in drug treatment.

We need research exploring how COVID-19 has affected those who report more problematic patterns of use, like people who regularly inject drugs.

This group may be disproportionately affected by COVID-19 given underlying health issues, poorer health literacy, stigma, and higher economic and social vulnerabilities.

In responding to the impacts of COVID-19 on drug use, we need to remember that evidence shows punitive responses to drug control increase social and economic costs. We believe our findings reinforce the importance of pursuing drug policies and research focused on health, human rights and harm reduction.

Read more: Women are drinking more during the pandemic, and it's probably got a lot to do with their mental health

We wish to acknowledge our research participants and the Australian Injecting & Illicit Drug Users League (AIVL) for their contribution to these projects.

If this article has raised issues for you, or if you’re concerned about someone you know, call the National Alcohol and Other Drug Hotline on 1800 250 015.

Authors: Amy Peacock, Senior Research Fellow, UNSW

Read more https://theconversation.com/pot-pills-and-the-pandemic-how-coronavirus-is-changing-the-way-we-use-drugs-141269

The US has bought most of the world's remdesivir. Here's what it means for the rest of us

Dimitri Karastelev/Unsplash, CC BYTo beat the coronavirus pandemic, countries need to collaborate. We need the best possible science to develop vaccines and drugs, and to test, track and contain the v...

Barbara Mintzes, Senior Lecturer, Faculty of Pharmacy, University of Sydney - avatar Barbara Mintzes, Senior Lecturer, Faculty of Pharmacy, University of Sydney

Why some people don't want to take a COVID-19 test

Last week, outgoing chief medical officer Brendan Murphy announced all returned travellers would be tested for COVID-19 before and after quarantine.Some were surprised testing was not already required...

Jane Williams, Researcher at the Centre for Values, Ethics and the Law in Medicine (VELiM), University of Sydney - avatar Jane Williams, Researcher at the Centre for Values, Ethics and the Law in Medicine (VELiM), University of Sydney

How To Make The Most Of Your Morning When You Have Small Children

It’s unclear how they got themselves organised when, for all we know, they can barely even tie their own shoes or drink from a glass without spilling it but, all the children in the world have man...

News Company - avatar News Company

Beginner’s Guide to Changing an Apple Watch Band

An Apple watch says a lot not only about the taste of the wearer but also his style. It shows you are on the head of the most recent things in innovation, and it flaunts your design sense. Custo...

Daisy Bell - avatar Daisy Bell

Victoria's coronavirus contact tracers are already under the pump. What happens next?

ShutterstockThe emergence of significant community transmission of COVID-19 in Melbourne over the past week is greatly concerning to the whole of Australia.Earlier this week, Victoria’s chief he...

Gerard Fitzgerald, Emeritus Professor, School of Public Health, Queensland University of Technology - avatar Gerard Fitzgerald, Emeritus Professor, School of Public Health, Queensland University of Technology

what's the new coronavirus saliva test, and how does it work?

A cornerstone of containing the COVID-19 pandemic is widespread testing to identify cases and prevent new outbreaks emerging. This strategy is known as “test, trace and isolate”.The standa...

Deborah Williamson, Professor of Microbiology, The Peter Doherty Institute for Infection and Immunity - avatar Deborah Williamson, Professor of Microbiology, The Peter Doherty Institute for Infection and Immunity

We looked at the health star rating of 20,000 foods and this is what we found

ShutterstockAs you read this, health officials are busy finalising the government’s review of the health star rating system on packaged foods.One of the issues the review is looking at is whethe...

Alexandra Jones, Research Fellow (Food Policy and Law), George Institute for Global Health - avatar Alexandra Jones, Research Fellow (Food Policy and Law), George Institute for Global Health

how Australia's past pandemics shape our COVID-19 response

Tensions over border closures are in the news again, now states are gradually lifting travel restrictions to allexcept Victorians.Prime Minister Scott Morrison says singling out Victorians is an overr...

Susan Moloney, Associate Professor, Paediatrics, Griffith University - avatar Susan Moloney, Associate Professor, Paediatrics, Griffith University

Rinnai Infinity Hot Water Systems

Most people wait until they experience the dreaded cold shower before taking action to replace their hot water system. The signs and symptoms of a failing system can be subtle but should not be ign...

Samantha Ball - avatar Samantha Ball

News Company Media Core

Content & Technology Connecting Global Audiences

More Information - Less Opinion